Does Aetna require metformin before Mounjaro?

Often, yes. Aetna's policy includes a metformin trial, or a documented reason you can't take it, as one path to approval. A separate path covers combination therapy when your A1C is 7.5% or higher, and renewals focus on showing your A1C improved.

What is Aetna's Mounjaro quantity limit?

Aetna sets a quantity limit in line with Mounjaro's once-weekly dosing, about four pens or vials a month. For the exact day-supply on your plan, check Aetna's current policy or your approval notice; if you need more, your doctor can request a quantity-limit exception.

How long does Aetna approve Mounjaro for?

Aetna approves Mounjaro for a set period, then requires renewal. Your approval letter lists your end date. When it's up, your doctor submits a continuation request showing you've been on a steady dose and your A1C improved.

What should I do if Aetna denies Mounjaro?

Read the denial reason first, then match it to the fix. Options include resubmitting with better documentation, requesting a peer-to-peer review or formulary exception, or filing an appeal. Your denial letter has your exact deadline.

Last verified: June 10, 2026The RX Index Editorial TeamDisclosure

Aetna Mounjaro Prior Authorization: Your 2026 Approval Checklist

The exact A1C and metformin rules Aetna checks, the packet your doctor needs to send, and the fastest fix for every denial reason — in one place.

Disclosure: The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. We may earn a commission if you use some provider links on this page — it never changes one word of the coverage facts below. This guide is general information, not medical advice.

Bottom line up front: Aetna almost always requires prior authorization for Mounjaro, and approval hinges on two things: a type 2 diabetes diagnosis and documented prior medication trials — including metformin, unless you can’t take it. If you want Mounjaro for weight loss without diabetes, the answer is almost always no, and the right lane is Wegovy or Zepbound. Find your situation in the table below, then skip to the section that matches.

Which Aetna Mounjaro lane are you in? Start here.

Find your row for the fast answer and your single best next move.

Your situation	The fast answer	Your best next move
Type 2 diabetes, new Mounjaro request	Strongest approval path -- if you've tried metformin or can't take it	Gather your A1C, diagnosis note, and prior medication history
High A1C (7.5%+), multiple diabetes meds not working	Combination-therapy path may apply	Have your doctor document current regimen failure + current A1C
Want it for weight loss only, no diabetes	Almost certainly no -- wrong drug for that use	Ask your doctor about Wegovy or Zepbound -- Aetna plans often prefer Wegovy
Already approved, need renewal	Aetna requires a renewal showing A1C improved	Have your doctor document dose history and current A1C vs. baseline
Aetna denied Mounjaro	Don't resubmit unchanged -- find the exact reason first	Read your denial letter, identify the one missing item, fix it
Quantity-limit or refill rejection	Different problem, different fix	Ask if it's a QL, refill-too-soon, dose-change, or renewal issue
No doctor who handles this	A prescriber has to submit the PA	Consider an insurance-aware telehealth visit

Find my lane → free 60-second quiz, no email needed

Does Aetna require prior authorization for Mounjaro?

In nearly all cases, yes — Aetna requires prior authorization for Mounjaro. Aetna defines prior authorization as your doctor getting approval from Aetna before the drug is covered, and Aetna’s clinical policy materials show specific Mounjaro PA criteria. “On the formulary” does not mean “approved for you” — it means the drug is on the list, but gated behind criteria your doctor must meet.

For many Aetna commercial plans, Mounjaro pharmacy benefits are managed through CVS Caremark. The criteria that matter most are set at the plan level, so confirm your specific plan’s rules in your drug list or by calling Member Services. The key point that applies broadly: Mounjaro is reviewed as a type 2 diabetes drug, and approval tracks the diabetes pathway.

Key PA terms Aetna and your pharmacy will use

Term	What it means in practice
Prior authorization (PA)	Your doctor sends Aetna proof you meet the criteria before the prescription is covered
Formulary	Your plan's drug list -- being listed doesn't mean automatic coverage
Quantity limit (QL)	About four pens or vials a month, in line with once-weekly dosing
Step therapy	Required prior drug trials before Aetna will cover Mounjaro
Formulary exception	A request to cover a drug outside normal criteria; your doctor argues medical necessity
Peer-to-peer review	Your prescriber calls Aetna's reviewing clinician to discuss the case directly -- often the fastest reversal route

What are Aetna’s Mounjaro prior authorization criteria?

Quick answer: Aetna’s Mounjaro criteria center on a type 2 diabetes diagnosis, an A1C above goal, and proof you’ve tried required prior medications — especially metformin. There are two main approval paths, and renewal adds a third check: that your A1C actually improved.

The two initial-approval paths

Path 1: Metformin step (most common)

Diagnosis of type 2 diabetes
A trial of metformin at the maximally tolerated dose — or a documented reason you can’t take it (intolerance, contraindication)
A1C above the plan’s goal threshold despite current treatment
No concurrent use of another GLP-1 agonist

Path 2: Combination therapy (high A1C)

Diagnosis of type 2 diabetes
A1C of 7.5% or higher despite multiple-agent therapy
Currently on a combination regimen that isn’t controlling blood sugar
No concurrent use of another GLP-1 agonist

Renewal / continuation criteria

When your approval expires, Aetna checks:

You’ve been on a stable, effective dose
Your A1C has improved from the baseline that was documented at initial approval
You’re still diagnosed with type 2 diabetes and still on treatment
No concurrent GLP-1 agonist use

Trap: if your A1C improved a lot, your renewal still needs to show why you need to stay on Mounjaro. Your doctor should document your baseline and your response, not just today’s number.

A1C thresholds: what Aetna actually checks

Review point	What Aetna looks for	What to prepare
Initial approval	A1C above goal -- criteria set the bar, often 7.5%+ on Path 2	Lab report with date; chart note confirming uncontrolled diabetes
Renewal	A1C improved from baseline; treatment documented as ongoing	Current lab vs. baseline; your doctor's note that treatment is still needed
Dose change	May trigger a new quantity-limit review	Prior approval dates; dose change rationale

The metformin rule: what counts as “tried it”

Aetna’s policy wants a real metformin trial — not a week’s attempt. A qualifying trial generally means:

✓ Genuine trial

You took metformin at the maximum tolerated dose for a meaningful period and your diabetes wasn't adequately controlled.

✓ Documented intolerance

A real side effect that made you stop -- documented in your chart notes. Mild, resolved GI upset typically doesn't count.

✓ Contraindication

A medical reason you can't take metformin at all (e.g., CKD with eGFR below threshold, certain contrast procedures).

✗ Not enough

"I tried it briefly and preferred something else." The chart note has to support the reason, not just the preference.

Get the Aetna Mounjaro PA checklist → free, no email

The exact documents to hand your prescriber so the request goes in complete

What your doctor should send so Aetna doesn’t deny for “missing information”

A prescription alone says “I want this.” A complete packet says “I meet your rules.” The most common fixable denial is “insufficient clinical information,” and the fix is a first submission that checks every box.

The Aetna Mounjaro PA packet (hand this to your doctor’s office)

Item	Why Aetna needs it	Where to get it
Member name, DOB, plan ID	Identifies the correct plan and criteria set	Insurance card, member portal
Diagnosis of type 2 diabetes + ICD-10 code	Confirms the covered indication	Chart notes, after-visit summary
A1C lab report with date	Shows blood-sugar control level vs. goal	Recent lab results (within ~3 months)
Metformin trial history -- dose, duration, result	Documents the step-therapy requirement	Pharmacy history, chart notes
Intolerance or contraindication note (if applicable)	Clears the metformin step when you can't take it	Chart note describing the side effect or contraindication
Current medication list	Rules out concurrent GLP-1 use	Kaiser/Aetna med list or pharmacy records
Prior medication failures (other diabetes meds)	Supports combination-therapy path if A1C >= 7.5%	Chart notes, pharmacy claims
Denial letter (if resubmitting or appealing)	Names the exact reason and the fix	Aetna mail, member portal, pharmacy

Message to send your prescriber

“Hi — Aetna says Mounjaro needs prior authorization. Could your office submit it with my type 2 diabetes diagnosis, my recent A1C, and documentation of my metformin trial (or why I can’t take it)? If the A1C is 7.5% or above and I’m already on a combination regimen, please note that too. If anything is denied, please send me the exact reason so I know whether it was missing information, step therapy, or a plan exclusion. Thank you.”

Three things not to do

Don't ask your doctor to document a diabetes diagnosis you don't have -- that's a compliance issue and the request will still fail.

Don't file an appeal before you've read the denial reason. The reason tells you the fix.

Don't assume "prior authorization required" means "denied." It just means Aetna wants proof first.

Does Aetna cover Mounjaro for weight loss?

Usually no — and this is the biggest reason Aetna Mounjaro requests get denied. Mounjaro is FDA-approved only for type 2 diabetes, and Aetna says many plans exclude weight-loss drugs. For weight management, the FDA-approved path is Wegovy (semaglutide) or Zepbound (tirzepatide) — and many Aetna plans currently prefer Wegovy on the weight-loss formulary.

If your real goal is…	Why Mounjaro isn’t the right request	The right lane to ask about
Weight loss only, no diabetes	Mounjaro not FDA-approved for weight loss; many plans exclude it	Wegovy or Zepbound -- check which one your Aetna plan covers
Obesity + sleep apnea	Mounjaro not indicated; wrong lane	Zepbound (FDA-approved for moderate-to-severe obstructive sleep apnea with obesity)
Heart disease + overweight	Not Mounjaro's lane	Wegovy (covered for some cardiovascular uses when criteria are met)
Prediabetes	Prediabetes doesn't meet the type 2 diabetes bar	Weight-management lane if you qualify, or ask about your plan's options

Want Mounjaro for weight loss? You may be in the wrong lane.

If weight management is your goal and Mounjaro is getting denied, the FDA-approved route is Wegovy or Zepbound. Ro offers a free GLP-1 Insurance Coverage Checker that contacts your insurer and tells you whether those drugs are covered and whether prior authorization is required. Ro supports Wegovy, Zepbound, and Ozempic, with an insurance concierge that handles PA paperwork. Membership is $39 for the first month, then as low as $74/month; medication billed separately. Ro does not offer Mounjaro itself.

Check Wegovy / Zepbound coverage with Ro → free

Sponsored. For Wegovy/Zepbound/Ozempic weight-loss path. Ro does not offer Mounjaro.

Aetna’s Mounjaro quantity limit and how long approvals last

Quantity limit: Aetna sets a quantity limit in line with Mounjaro’s once-weekly dosing — about four pens or vials per month. For the exact day-supply on your plan, check your approval notice or Aetna’s current policy. If you need more (for example, a dose increase), your doctor can request a quantity-limit exception.

Approval duration: Aetna approves Mounjaro for a set period, then requires renewal. Your approval letter will list the end date. Before it expires, your doctor submits a continuation request that must show you’ve been on a stable, effective dose and that your A1C improved from baseline. Don’t wait for the rejection — start the renewal process a few weeks before your approval runs out.

Refill or dose-change rejections are separate from PA denials. If the pharmacy rejects a refill, first confirm whether it’s a quantity-limit issue, a refill-too-soon edit, or an expired PA. The fix is different for each.

The Aetna Mounjaro prior authorization form and contact numbers

Your prescriber submits the prior authorization — not you. Aetna processes most PA requests through its online portal, by phone, or via CVS Caremark (for plans that use CVS as the pharmacy benefit manager). You gather the documentation; your doctor’s office sends the request.

Who	What to do	Contact / where
Your prescriber	Submits the PA electronically through Aetna's provider portal or by fax/phone using Aetna's PA form	Aetna provider line or CVS Caremark PA line (for CVS-managed plans) -- number on the prescription benefit card
You (member)	Gather records, call with status questions, check your approval online	Aetna member portal (aetna.com) → My Prescriptions / Pharmacy; or call the number on your member ID card
Your plan's PBM (CVS Caremark for many plans)	Processes the pharmacy PA	CVS Caremark: 1-800-294-5979 (confirm with your card)

Finding the right form: Don’t download a generic Aetna PA form and assume it’s current. Ask your prescriber’s office to pull the form directly from Aetna’s provider portal or CVS Caremark’s system — the form that matches your plan and your diagnosis pathway.

Why Aetna denies Mounjaro — and the exact fix for each reason

Your denial letter is the map. Almost every Aetna Mounjaro denial falls into one of six buckets, and each has a specific next move. Read the letter before you do anything else.

What the letter says	What it usually means	Your best move
"Insufficient clinical information" / medical necessity not established	Most common, most fixable -- the packet was thin	Resubmit with diagnosis notes, current A1C, and metformin trial history
"Step therapy not completed" / must try preferred drug first	Metformin trial or other step wasn't documented	Document the trial with dates and result, or the intolerance/contraindication note
"Not FDA-approved for the requested use" / off-label	Requested for weight loss or another non-diabetes use	If you have T2D: correct the indication. If not: move to Wegovy/Zepbound lane
"Concurrent GLP-1 use"	Another GLP-1 is already on your record	Confirm the current med list; if switching, document the stop date
"Excluded under your benefit" / plan exclusion	Your plan excludes this drug class -- hardest to overturn	Check your Evidence of Coverage; ask about a benefit exception or the savings card
"Quantity limit exceeded"	Dose or supply exceeded the monthly limit	Match the plan's quantity rules or have your doctor request a QL exception

When an appeal is worth it

Letter says “missing information” and you have that information
A1C and metformin trial are in your chart but weren’t submitted
Your plan misapplied a step-therapy rule
The drug is covered but the criteria were misread

When an appeal usually wastes time

Your plan flatly excludes weight-loss drugs
Requesting Mounjaro for weight loss with no type 2 diabetes
Diagnosis code doesn’t match your chart
Your prescriber won’t support the request

How to file an Aetna appeal

Your denial letter is the source of truth for your appeal. It names the reason, the deadline, the appeal level, and where to send the request. Follow your letter.

Mind the deadline. Aetna commercial plan appeals are commonly filed within 180 days of the denial, but your letter states your exact window.
Ask for a peer-to-peer review first. Your prescriber calling Aetna’s reviewing clinician directly is often the fastest way to reverse a denial.
File the written appeal using the address, fax, and instructions on your denial letter — not a generic online form.
Request an expedited appeal if waiting could harm your health. Those are typically decided within 72 hours.
Escalate to external review if internal appeals fail. You can request an independent review through your state’s insurance regulator.

Decode my Aetna denial reason → get my exact next step

What Mounjaro costs with Aetna — and the savings-card math

Once approved, your out-of-pocket depends on your plan’s tier and deductible. Without coverage, Mounjaro’s list price is $1,112.16 per fill (four pens, a one-month supply). With commercial insurance and a type 2 diabetes prescription, Lilly’s Mounjaro Savings Card can bring eligible patients to as little as $25 per fill. The card expires December 31, 2026 and cannot be used with government plans.

Situation	What the Mounjaro Savings Card does	Fine print
Aetna commercial plan that covers Mounjaro (PA approved, T2D)	Pay as little as $25 per 1-, 2-, or 3-month fill	Max savings $150/mo, up to $1,950/year; up to 13 fills; 18+, U.S. resident, T2D prescription required
Aetna commercial plan that does NOT cover Mounjaro	Pay as low as $499 for a one-month fill	Up to $8,411/year; same eligibility rules
Medicare, Medicaid, TRICARE, VA, or other government plan	Not eligible for the savings card	Federal rules exclude all government plans; no workaround

Coupon warning: The Mounjaro Savings Card requires an FDA-approved use — type 2 diabetes. If your prescription is for off-label weight loss, the card won’t apply. Always confirm current terms on Lilly’s site the day you enroll.

See the full Mounjaro savings card guide →

If you need help: insurance-aware telehealth options

A PA requires a prescriber’s support — you gather the records, but the clinical request has to come from a doctor. If your current prescriber doesn’t handle GLP-1 paperwork, two options cover different needs.

Provider	Best for	Handles Mounjaro?	Submits Aetna PA?	Starting cost
Your own doctor + Aetna	Anyone with type 2 diabetes	Yes	Yes (your prescriber)	Your copay
Sesame (telehealth)	Wanting a provider visit + Mounjaro conversation	Yes, if clinically appropriate	Provider can assist	~$1,080–$1,300/mo cash for medication
Ro (weight-loss program)	Weight-loss goal; exploring Wegovy/Zepbound	No (doesn't offer Mounjaro)	Yes, for meds Ro supports	$39 first month, then from $74/mo
Your employer / plan sponsor	Fighting a benefit exclusion	N/A	No	Free -- ask about exceptions

Sesame — for a provider visit and a Mounjaro-specific conversation

Sesame lets you book a provider visit, and a Sesame provider can assist with prior authorization paperwork if clinically appropriate. Sesame lists Mounjaro at about $1,080–$1,300 per month without insurance. Best if you need a provider visit and a Mounjaro-specific diabetes conversation.

See Sesame’s Mounjaro visit options →

Sponsored. Best for a provider visit + PA help if clinically appropriate. Diabetes path only.

Ro — free coverage check before you pick a weight-loss path

Ro’s free GLP-1 Insurance Coverage Checker contacts your insurer and tells you whether Wegovy, Zepbound, or Ozempic is covered and whether prior authorization is required. Ro’s insurance concierge then handles the PA and appeals. Ro does not offer Mounjaro and its insurance service covers the weight-loss medications it supports.

Check Wegovy / Zepbound coverage with Ro → free

Sponsored. Weight-loss path only. Ro does not offer Mounjaro.

How we verified this guide

We reviewed Aetna’s published clinical policy materials for Mounjaro, the FDA prescribing information for Mounjaro and Zepbound, Eli Lilly’s current pricing and savings-card terms, and provider guides for Aetna PA submission. This page does not guarantee coverage. Your specific Aetna plan’s formulary, your diagnosis, and your prescriber’s documentation control the final decision.

What we verified	Primary source	Status
Mounjaro FDA approval (T2D, adults + children 10+); boxed warning; contraindications	FDA/Lilly Mounjaro Prescribing Information	Verified
Zepbound FDA approval (weight management; sleep apnea)	FDA/Lilly Zepbound Prescribing Information	Verified
Aetna PA criteria: type 2 diabetes, metformin step, A1C thresholds, renewal requirements, quantity limit	Aetna clinical policy materials (Mounjaro PA criteria)	Verified
Aetna commercial plans often managed through CVS Caremark pharmacy benefit	Aetna plan documents and CVS Caremark provider guide	Verified
Mounjaro list price ($1,112.16/fill); savings-card tiers; government exclusions; expiration 12/31/2026	Eli Lilly pricing and Mounjaro Savings Card terms	Verified
Wegovy preferred on many Aetna weight-loss formularies	Aetna formulary materials	Verified

Last verified: June 10, 2026. Aetna updates formularies quarterly; confirm your specific plan at aetna.com or by calling Member Services.

Aetna Mounjaro prior authorization FAQ

Quick answers to the most common questions about Aetna’s Mounjaro coverage, criteria, denials, and costs.

Does Aetna require prior authorization for Mounjaro?: In nearly all cases, yes. Aetna's materials show Mounjaro prior authorization criteria, and Aetna defines prior authorization as your doctor getting approval before the drug is covered. Check your specific plan's drug list to confirm.
Does Aetna cover Mounjaro for weight loss?: Usually no. Mounjaro isn't FDA-approved for weight loss, and Aetna says many plans exclude weight-loss drugs. The approved weight-loss route is Zepbound or Wegovy, and many Aetna plans currently prefer Wegovy.
Does Aetna require metformin before Mounjaro?: Often, yes. Aetna's policy includes a metformin trial, or a documented reason you can't take it, as one path to approval. A separate path covers combination therapy when your A1C is 7.5% or higher, and renewals focus on showing your A1C improved.
What is Aetna's Mounjaro quantity limit?: Aetna sets a quantity limit in line with Mounjaro's once-weekly dosing, about four pens or vials a month. For the exact day-supply on your plan, check Aetna's current policy or your approval notice; if you need more, your doctor can request a quantity-limit exception.
How long does Aetna approve Mounjaro for?: Aetna approves Mounjaro for a set period, then requires renewal. Your approval letter lists your end date. When it's up, your doctor submits a continuation request showing you've been on a steady dose and your A1C improved.
What should I do if Aetna denies Mounjaro?: Read the denial reason first, then match it to the fix. Options include resubmitting with better documentation, requesting a peer-to-peer review or formulary exception, or filing an appeal. Your denial letter has your exact deadline.

Still not sure which GLP-1 program is right for you?

Take our free 60-second matching quiz. Answer a few questions and get a personalized action plan for your exact situation — Aetna appeal, switch to Wegovy, or something else entirely.

Get my free action plan → 60 seconds Weight-loss goal? Check Wegovy / Zepbound coverage with Ro → free

Sponsored. Weight-loss path only. Ro does not offer Mounjaro.

Related guides

By The RX Index Editorial Team. The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. This guide is general information, not medical advice, and does not guarantee Aetna coverage. Verify your benefits with your plan; all treatment decisions require a licensed clinician. Last verified: June 10, 2026.

Primary sources

FDA/Lilly -- Mounjaro (tirzepatide) Prescribing Information (type 2 diabetes indication; boxed warning; contraindications)
FDA/Lilly -- Zepbound (tirzepatide) Prescribing Information (chronic weight management; obstructive sleep apnea)
Aetna -- Clinical Policy Bulletin and prior authorization materials for Mounjaro (tirzepatide)
CVS Caremark -- prior authorization process and provider guide (Aetna commercial plans)
Eli Lilly -- Mounjaro pricing and Savings Card terms (pricinginfo.lilly.com; mounjaro.lilly.com/savings-resources)
Ro -- GLP-1 Insurance Coverage Checker and weight-loss program pages
Sesame -- Mounjaro provider and pricing page